Vice President for Immunobiology
Chair and Regental Professor
Department of Immunology;
Founding Director
James P Allison Institute;
The University of Texas MD Anderson Cancer Center
Houston, Texas
For lifelong scientific achievements and transformative contributions to cancer research and patient care that have revolutionized cancer treatment and revitalized the cancer immunology field. Most notably, his pioneering discovery and development of immune checkpoint blockade immunotherapy, including the identification of CTLA-4 as a negative regulator of T-cell activation and the translation of this insight into a first-in-class therapy. Through these landmark contributions, as well as his scientific leadership in advancing the future of immuno-oncology, Dr. Allison has had an unparalleled impact on the cancer field, reshaping its scientific direction and improving the lives of patients worldwide.
The AACR Award for Lifetime Achievement in Cancer Research was established in 2004 to honor an individual who has made significant fundamental contributions to cancer research, either through a single scientific discovery or a body of work. These contributions, whether in research, leadership, or mentorship, must have had a lasting impact on the cancer field and must have demonstrated a lifetime commitment to progress against cancer. To learn more please visit the press release.
View Dr. Allison’s Fellows of the AACR Academy page.
View Past Recipients.